Clinical Trial Update: A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating high-dose intravenous ascorbate added to chemotherapy and radiation therapy for non-small cell lung cancer. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Ascorbate (high-dose intravenous vitamin C) (ascorbic acid)

Snippet

Sponsor: Joseph J. Cullen, MD, FACS | Conditions: Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING